Go Pro
OTCMKTS:FUJIY

Fujifilm Q3 2025 Earnings Report

Fujifilm logo
$11.70 +0.23 (+2.01%)
As of 03:59 PM Eastern

Fujifilm EPS Results

Actual EPS
$0.19
Consensus EPS
$0.20
Beat/Miss
Missed by -$0.01
One Year Ago EPS
N/A

Fujifilm Revenue Results

Actual Revenue
N/A
Expected Revenue
$813.35 billion
Beat/Miss
N/A
YoY Revenue Growth
N/A

Fujifilm Announcement Details

Quarter
Q3 2025
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Upcoming Earnings

Fujifilm's next earnings date is estimated for Thursday, August 6, 2026, based on past reporting schedules.

Conference Call Resources

Fujifilm Earnings Headlines

The REAL Reason Trump is Invading Iran
For a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Because my research has led me to believe we’re risking World War 3 with Iran for a completely different reason.tc pixel
See More Fujifilm Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Fujifilm? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Fujifilm and other key companies, straight to your email.

About Fujifilm

Fujifilm (OTCMKTS:FUJIY) (OTCMKTS:FUJIY) is a Tokyo-based multinational conglomerate originally founded in 1934 as Fuji Photo Film Co., Ltd. Over the decades the company has evolved from a photographic film manufacturer into a diversified technology group operating across imaging, information, highly functional materials and healthcare. Fujifilm Holdings Corporation serves customers worldwide with a combination of hardware, consumables, software and services.

The company’s product and service portfolio spans consumer and professional imaging products, commercial and industrial printing systems, and office document solutions including printers and copiers. Fujifilm also develops and supplies highly functional materials and components used in electronics and manufacturing, such as specialty films, coatings and display materials. In healthcare and life sciences, the group offers diagnostic imaging systems, endoscopy equipment, in vitro diagnostics, and has a growing presence in pharmaceuticals and biopharmaceutical contract development and manufacturing.

Fujifilm conducts research and development through global R&D centers and operates manufacturing and sales networks across Asia, Europe, the Americas and other regions, supporting both local markets and international customers. The company’s strategy in recent years has emphasized diversification away from traditional photographic film into higher-growth areas such as medical technologies, bioprocessing services and advanced materials, leveraging its chemical and imaging expertise.

As a holdings group, Fujifilm is managed through an executive team based in Tokyo and a portfolio of operating subsidiaries that focus on specific markets and technologies. The company is known for technology-driven partnerships, investments in R&D and an ability to apply core competencies across consumer, industrial and healthcare sectors.

View Fujifilm Profile